Internal Server Error

About Ventures West

Ventures West is a venture capital firm founded in 1973. It is primarily based out of Vancouver, Canada. As of Apr 2013, Ventures West has invested in 69 companies. It primarily invests in Series B round in Canada based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to Life Sciences and High Tech. Most recently it participated in the $***** Series C round of Aquinox Pharma Overall, Ventures West portfolio has seen 5 IPOs and 33 acquisitions including key companies like PowerSchool, MACOM and Xenon Pharmaceuticals. A lot of funds co-invest with Ventures West, with names like BDC sharing a substantial percentage of its portfolio. Ventures West has team of 3 people including 2 partners.
Key Metrics
Portfolio Count
Portfolio Locations
Rounds of Entry
Series A, Series B & 4 more
Portfolio Acquisitions

Ventures West's List of Top Investments

Ventures West has a portfolio of 69 companies. Their most notable investments are in Dabble DB and OncoGenex Technologies.Their portfolio spans across Canada, United States, Germany and 1 more locations. They have invested in Enterprise Applications, Life Sciences, High Tech and 23 other sectors, across stages such as Series A, Series B  and 4 more. Here is the list of top investments by Ventures West:
Provider of software and cloud-based solutions for K-12 education. The company offers student information, personalized learning, and student success solutions. It also provides tools for college and career readiness, talent recruitment, and resource planning. Data analytics, communication, and artificial intelligence solutions are available.

Key facts about PowerSchool

Manufacturer of RF, microwave, millimeter wave, and optical networking components. The company provides amplifiers, attenuators, diodes, filters, integrated circuits, limiters, modules, photodetectors, and switches. Products support aerospace, broadcast video, CATV, data centers, industrial, medical, and telecommunications applications. The company also offers foundry and design services.

Key facts about MACOM

Developer of small molecule drugs against rare channelopathies. They have built a core enabling discovery platform for the discovery of validated drug targets by studying rare human diseases with extreme traits, including diseases caused by mutations in ion channels, known as channelopathies. The company has a proprietary discovery platform, Extreme Genetics which involves the study of families where individuals exhibit inherited severe traits or phenotypes. With Teva, they are developing TV-45070, a topical Sodium Channel Inhibitor for the treatment of pain.

Key facts about Xenon Pharmaceuticals

Distribution of multi-screen video to IP-connected devices solutions provider. It offers solutions for multi-channel video program distributors and content providers to launch and scale OTT video services to the home and on the go. It provides an open and modular platform for IPTV set-top boxes and unmanaged OTT devices for live, video-on-demand, and monetization services including ad insertion, personalization, and subscription-based content.

Key facts about Quickplay

  • Founded Year: 2004
  • Location: Toronto (Canada)
  • Last Known Valuation: $*****
  • Stage: Acquired
  • Total Funding till date: $84.6M
  • Employee Count: 38 as on Sep 30, 2026
  • Investors: Stifel, ORIX and 8 Others
  • Latest Funding Round: PE, Mar 26, 2015, $*****
  • Highlight: Acquired
AudienceView provides ticketing and e-commerce solutions for sports venues, not-for-profit arts organizations, regional ticketing agencies, arenas, film festivals, theaters, college athletics, professional sports teams, and race tracks. Products include 'AudienceView', 'OvationTix', 'TheaterMania', and 'WhatsOnStage'. Features include CRM, white-label online ticketing, marketing, fundraising, content management, venue management, and analytics. Customers include Denver Center of Performing Arts, Yale University, ATG Tickets, Geffen Playhouse, mIrvish, MoshTix, The Ticket Factory among others.

Key facts about AudienceView

Ventures West's Investments by Stage

Ventures West has made 13 investments in Series A stage with an average round size of $9.77M, 11 investments in Series B stage with an average round size of $15.2M and 5 investments in Series C stage with an average round size of $26.7M.
Here are Ventures West's investments by stage:
Stage of entry
No. of Investments
Series A
13
Series B
11
Series C
5
Post IPO
1
Seed
1
Others
1
Breakdown of Ventures West's investments by stage of entrySeries A (13)Series B (11)
Note: We have considered here, only first round of investments

Ventures West's Investments by Sector

Ventures West has a diverse portfolio, with companies operating in the Life Sciences, High Tech, Enterprise Applications, Semiconductors and Sustainability Tech. Notably, it has invested in 48 Enterprise (B2B) companies, 44 Tech companies, 22 Software companies and at least 10 companies focusing on Tech hardware.
Here are Ventures West's investments by sector:
Sector
No. of Investments
Life Sciences
12
High Tech
6
Enterprise Applications
5
Semiconductors
4
Sustainability Tech
4
Others
18
Breakdown of Ventures West's investments by sectorsLife Sciences (12)High Tech (6)
Note: We have considered here, only first round of investments

Ventures West's Investments by Geography

Ventures West has made most investments in Canada (21), followed by United States where it has made 11 investments.
Here are Ventures West's investments by geography:
Country
No. of Investments
Canada
21
United States
11
Breakdown of Ventures West's investments by countriesCanada (21)United States (11)
Note: We have considered here, only first round of investments

Ventures West's recent investments

Ventures West has not made any investment in 2026 so far.
Here are the most recent investments by Ventures West:
Date
Company
Location
Round Details
Round Amount
Co-Investors
Apr 01, 2013
Canada
Series C
5410
  [+3]
Aug 14, 2012
United States
Series B
9000
Apr 19, 2012
United States
Series D
1222
Jun 28, 2011
Canada
Series C
7148
Sep 29, 2010
Canada
Series B
6409

IPOs and Publicly Listed companies in Ventures West's Portfolio

5 of Ventures West's portfolio companies have become public. Xenon Pharmaceuticals got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Nov 2014 at marketcap of $122M and MacroGenics got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ) at marketcap of $384M.
Here are Ventures West's portfolio companies that went public:
Company
IPO Date
First Invested on
First Round of Investment
Round Size
Nov 05, 2014
Apr 04, 2001
Series C
2438
Oct 10, 2013
May 17, 2006
Series C
3565
Mar 15, 2012
Jun 10, 2002
Series A
1063
Jun 09, 1993
-
-
5236
-
Aug 03, 2007
Series C
4624

Acquired companies in Ventures West's Portfolio

33 companies from Ventures West's portfolio have been acquired. The most recent acquisition was Spectra7 in Mar 2025 by Parade Tech for $*****.
Here are Ventures West's portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
Mar 07, 2025
Aug 14, 2012
Series B
8501
Jun 07, 2024
-
-
6366
Jul 29, 2020
Jun 12, 2007
Series A
1369
Mar 03, 2020
Sep 19, 2007
Series C
4689
Sep 16, 2019
Aug 09, 2005
Series A
3389

Team profile of Ventures West

Ventures West has a team of 3 members including 2 Partners located in Canada. Ventures West's team does not sit on the board of any company as of now.

Co-investors of Ventures West

Over the past 25 years, 154 investors have co-invested in Ventures West's portfolio companies. This includes funds and angels.

  • Invested before Ventures West: BDC, GrowthWorks Capital and 18 others have invested in rounds before Ventures West. There are 2 companies where BDC has invested before Ventures West and 2 companies where GrowthWorks Capital has invested before Ventures West.
  • Top Co-investors of Ventures West: 62 investors entered a company along with Ventures West. These include investors like BDC (9 companies).
  • Invested after Ventures West: A total of 72 investors have invested in Ventures West's portfolio after their investments. Top Investors include CMEA Capital (2 companies), Delphi Ventures (2 companies) and H.I.G. Capital (2 companies).

Recent News related to Ventures West

•
Dow Jones•Apr 20, 2012•Alder Biopharmaceuticals, Sevin Rosen, Ventures West, Washington Research Foundation and 4 others
•
QuickPlay Media Raises $12 Million - PE HubPE Hub•Jul 13, 2009•Quickplay, GMP Securities, Ventures West, General Catalyst and 1 other
•
View all news related to Ventures West

FAQs about Ventures West

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford